Effects of Obesity on Feet, Knees & Lower-Body Mechanics Messier, S
In clinical trials, specific agents have demonstrated significant benefits in glycemic control, with some (liraglutide, semaglutide, and dulaglutide) showing cardiovascular risk reduction in dedicated outcome trials
While gastrointestinal symptoms dominate the adverse effect profile, patients and clinicians have increasingly questioned whether these medications might contribute to musculoskeletal complaints, including muscle pain, weakness, or discomfort
Report any significant changes to your healthcare team promptly
Consistency in timing becomes even more important for establishing a predictable pattern you can plan around